Secretory defects induced by immunosuppressive agents on human pancreatic β-cells

L. Polastri, F. Galbiati, F. Bertuzzi, P. Fiorina, R. Nano, S. Gregori, L. Aldrighetti, G. Pozza, A. Secchi, L. Adorini, A. M. Davalli

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Despite the considerable interest for islet and pancreas transplantation, remarkably little is known about the direct effects of immunosuppressive drugs on human β-cell function. We measured different insulin secretory parameters and insulin gene expression of human islets cultured for 5 days in the presence of mycophenolate mofetil (MMF), cyclosporin A (CsA), tacrolimus (FK506) or a mixture of 3 cytokines. Basal insulin release after exposure to cytokines and FK506 was significantly higher than in control islets. Responsiveness to an acute glucose stimulus did not differ significantly between control and treated islets. However, absolute incremental insulin responses (Δ-AUCs) of islets exposed to cytokines or FK506 were significantly higher compared to islets exposed to CsA or MMF, mainly because of the higher basal release. Indeed, maximal over basal release (stimulation index, SI) tended to be lower in islets exposed to FK506 than in control islets. Insulin gene expression was significantly reduced only in islets exposed to CsA. FK506 was, among those tested, the immunosuppressive drug that most profoundly altered the normal insulin secretory pattern of human β-cells, whereas CsA was the only inhibiting insulin gene expression. Although the abnormalities induced by the immunosoppressive drugs utilized in this study were modest, these in vitro data are consistent with the reported in vivo diabetogenicity of CsA and FK506 and point to MMF as the ideal immunosuppressive agent from a pancreatic β-cell point of view.

Original languageEnglish
Pages (from-to)229-233
Number of pages5
JournalActa Diabetologica
Volume39
Issue number4
DOIs
Publication statusPublished - Dec 2002

Fingerprint

Tacrolimus
Immunosuppressive Agents
Insulin
Cyclosporine
Mycophenolic Acid
Cytokines
Gene Expression
Drug-Induced Abnormalities
Pancreas Transplantation
Islets of Langerhans Transplantation
Pharmaceutical Preparations
Area Under Curve
Glucose

Keywords

  • Human islet
  • Immunosuppressive agents
  • Insulin gene
  • Insulin secretion

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Secretory defects induced by immunosuppressive agents on human pancreatic β-cells. / Polastri, L.; Galbiati, F.; Bertuzzi, F.; Fiorina, P.; Nano, R.; Gregori, S.; Aldrighetti, L.; Pozza, G.; Secchi, A.; Adorini, L.; Davalli, A. M.

In: Acta Diabetologica, Vol. 39, No. 4, 12.2002, p. 229-233.

Research output: Contribution to journalArticle

Polastri, L, Galbiati, F, Bertuzzi, F, Fiorina, P, Nano, R, Gregori, S, Aldrighetti, L, Pozza, G, Secchi, A, Adorini, L & Davalli, AM 2002, 'Secretory defects induced by immunosuppressive agents on human pancreatic β-cells', Acta Diabetologica, vol. 39, no. 4, pp. 229-233. https://doi.org/10.1007/s005920200039
Polastri, L. ; Galbiati, F. ; Bertuzzi, F. ; Fiorina, P. ; Nano, R. ; Gregori, S. ; Aldrighetti, L. ; Pozza, G. ; Secchi, A. ; Adorini, L. ; Davalli, A. M. / Secretory defects induced by immunosuppressive agents on human pancreatic β-cells. In: Acta Diabetologica. 2002 ; Vol. 39, No. 4. pp. 229-233.
@article{e61624496aac4b1ea1eab86e44363c8b,
title = "Secretory defects induced by immunosuppressive agents on human pancreatic β-cells",
abstract = "Despite the considerable interest for islet and pancreas transplantation, remarkably little is known about the direct effects of immunosuppressive drugs on human β-cell function. We measured different insulin secretory parameters and insulin gene expression of human islets cultured for 5 days in the presence of mycophenolate mofetil (MMF), cyclosporin A (CsA), tacrolimus (FK506) or a mixture of 3 cytokines. Basal insulin release after exposure to cytokines and FK506 was significantly higher than in control islets. Responsiveness to an acute glucose stimulus did not differ significantly between control and treated islets. However, absolute incremental insulin responses (Δ-AUCs) of islets exposed to cytokines or FK506 were significantly higher compared to islets exposed to CsA or MMF, mainly because of the higher basal release. Indeed, maximal over basal release (stimulation index, SI) tended to be lower in islets exposed to FK506 than in control islets. Insulin gene expression was significantly reduced only in islets exposed to CsA. FK506 was, among those tested, the immunosuppressive drug that most profoundly altered the normal insulin secretory pattern of human β-cells, whereas CsA was the only inhibiting insulin gene expression. Although the abnormalities induced by the immunosoppressive drugs utilized in this study were modest, these in vitro data are consistent with the reported in vivo diabetogenicity of CsA and FK506 and point to MMF as the ideal immunosuppressive agent from a pancreatic β-cell point of view.",
keywords = "Human islet, Immunosuppressive agents, Insulin gene, Insulin secretion",
author = "L. Polastri and F. Galbiati and F. Bertuzzi and P. Fiorina and R. Nano and S. Gregori and L. Aldrighetti and G. Pozza and A. Secchi and L. Adorini and Davalli, {A. M.}",
year = "2002",
month = "12",
doi = "10.1007/s005920200039",
language = "English",
volume = "39",
pages = "229--233",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia s.r.l.",
number = "4",

}

TY - JOUR

T1 - Secretory defects induced by immunosuppressive agents on human pancreatic β-cells

AU - Polastri, L.

AU - Galbiati, F.

AU - Bertuzzi, F.

AU - Fiorina, P.

AU - Nano, R.

AU - Gregori, S.

AU - Aldrighetti, L.

AU - Pozza, G.

AU - Secchi, A.

AU - Adorini, L.

AU - Davalli, A. M.

PY - 2002/12

Y1 - 2002/12

N2 - Despite the considerable interest for islet and pancreas transplantation, remarkably little is known about the direct effects of immunosuppressive drugs on human β-cell function. We measured different insulin secretory parameters and insulin gene expression of human islets cultured for 5 days in the presence of mycophenolate mofetil (MMF), cyclosporin A (CsA), tacrolimus (FK506) or a mixture of 3 cytokines. Basal insulin release after exposure to cytokines and FK506 was significantly higher than in control islets. Responsiveness to an acute glucose stimulus did not differ significantly between control and treated islets. However, absolute incremental insulin responses (Δ-AUCs) of islets exposed to cytokines or FK506 were significantly higher compared to islets exposed to CsA or MMF, mainly because of the higher basal release. Indeed, maximal over basal release (stimulation index, SI) tended to be lower in islets exposed to FK506 than in control islets. Insulin gene expression was significantly reduced only in islets exposed to CsA. FK506 was, among those tested, the immunosuppressive drug that most profoundly altered the normal insulin secretory pattern of human β-cells, whereas CsA was the only inhibiting insulin gene expression. Although the abnormalities induced by the immunosoppressive drugs utilized in this study were modest, these in vitro data are consistent with the reported in vivo diabetogenicity of CsA and FK506 and point to MMF as the ideal immunosuppressive agent from a pancreatic β-cell point of view.

AB - Despite the considerable interest for islet and pancreas transplantation, remarkably little is known about the direct effects of immunosuppressive drugs on human β-cell function. We measured different insulin secretory parameters and insulin gene expression of human islets cultured for 5 days in the presence of mycophenolate mofetil (MMF), cyclosporin A (CsA), tacrolimus (FK506) or a mixture of 3 cytokines. Basal insulin release after exposure to cytokines and FK506 was significantly higher than in control islets. Responsiveness to an acute glucose stimulus did not differ significantly between control and treated islets. However, absolute incremental insulin responses (Δ-AUCs) of islets exposed to cytokines or FK506 were significantly higher compared to islets exposed to CsA or MMF, mainly because of the higher basal release. Indeed, maximal over basal release (stimulation index, SI) tended to be lower in islets exposed to FK506 than in control islets. Insulin gene expression was significantly reduced only in islets exposed to CsA. FK506 was, among those tested, the immunosuppressive drug that most profoundly altered the normal insulin secretory pattern of human β-cells, whereas CsA was the only inhibiting insulin gene expression. Although the abnormalities induced by the immunosoppressive drugs utilized in this study were modest, these in vitro data are consistent with the reported in vivo diabetogenicity of CsA and FK506 and point to MMF as the ideal immunosuppressive agent from a pancreatic β-cell point of view.

KW - Human islet

KW - Immunosuppressive agents

KW - Insulin gene

KW - Insulin secretion

UR - http://www.scopus.com/inward/record.url?scp=0036905423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036905423&partnerID=8YFLogxK

U2 - 10.1007/s005920200039

DO - 10.1007/s005920200039

M3 - Article

VL - 39

SP - 229

EP - 233

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 4

ER -